| 2026-04-03 |
停牌提示：
2026-04-02 19:50:00 停牌:
停牌原因 ▼▲
- 原因：
- Halt - News Pending_x000D_
Trading is halted pending the release of material news.
|
| 2026-04-03 |
详情>>
拆分方案：
每8.0000合并分成1.0000股
|
| 2026-03-31 |
详情>>
业绩披露：
2025年年报每股收益-11.42美元,归母净利润-8558万美元,同比去年增长-385.15%
|
| 2026-02-26 |
股东大会：
将于2026-03-25召开股东大会
会议内容 ▼▲
- 1.To approve any amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s Class A common stock, $0.01 par value per share (the “Common Stock”), within a range of 1-for-5 to 1-for-15 (or any number in between), without reducing the authorized number of shares of the Common Stock (the “Reverse Stock Split”), and the filing of a final amendment with the ratio within such range to be determined in the sole discretion of the Board of Directors of the Company (the “Board”) at any time on or before April 30, 2026, without further approval or authorization of our stockholders (the “Reverse Stock Split Proposal”);
2.To consider and vote upon an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal.
|
| 2026-02-26 |
详情>>
股本变动：
变动后总股本503.96万股
|
| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-19.88美元,归母净利润-1601.5万美元,同比去年增长-80.65%
|
| 2025-11-10 |
股东大会：
将于2025-12-01召开股东大会
会议内容 ▼▲
- 1.To elect the five director nominees named in the Proxy Statement;
2.To ratify the appointment of PKF O’Connor Davies, LLP (“PKF”) as our independent registered public accounting firm for our fiscal year ending December 31, 2025;
3.To increase the number of shares eligible for sale under the Company’s 2019 Equity Incentive Plan (the “2019 Equity Incentive Plan”) to 3,000,000 shares;
4.To approve, in accordance with Nasdaq listing rule 5635(a), the issuance of 3,328,012 shares of the Company’s common stock and pre-funded warrants to acquire in the aggregate up to 25,294,068 shares of the Company’s common stock (the “Financing Proposal”);
5.To approve in accordance with Nasdaq Listing Rule 5635(c), the issuance of pre-funded warrants (the “Advisory Warrants”), and shares of common stock upon exercise of Advisory Warrants (the “Advisory Compensation Proposal”);
6.To transact such other business as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) of the Annual Meeting.
|
| 2025-10-20 |
详情>>
内部人交易：
Sher Barbara等共交易4笔
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-13.92美元,归母净利润-708.2万美元,同比去年增长-38.7%
|
| 2025-06-24 |
详情>>
拆分方案：
每750.0000合并分成1.0000股
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.32美元,归母净利润-386.7万美元,同比去年增长13.89%
|
| 2025-05-13 |
股东大会：
将于2025-06-16召开股东大会
会议内容 ▼▲
- 1.To grant discretionary authority to our board of directors to (i) amend our articles of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-two hundred fifty (1-for-250) to a maximum of a one-for-five hundred (1-for-500)], with the exact ratio to be determined by our board of directors in its sole discretion; (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Stock Split Proposal”)
2.To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Reverse Stock Split Proposal if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal (the “Adjournment Proposal”)
3.To consider and transact such other business as may be properly brought before the Special Meeting and any adjournments thereof.
|
| 2025-05-09 |
股东大会：
将于2025-06-05召开股东大会
会议内容 ▼▲
- 1.To grant discretionary authority to our board of directors to (i) amend our articles of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-two hundred fifty (1-for-250) to a maximum of a one-for-five hundred (1-for-500)], with the exact ratio to be determined by our board of directors in its sole discretion; (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Stock Split Proposal”)
2.To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Reverse Stock Split Proposal if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal (the “Adjournment Proposal”)
3.To consider and transact such other business as may be properly brought before the Special Meeting and any adjournments thereof.
|
| 2025-03-21 |
详情>>
业绩披露：
2024年年报每股收益-14.56美元,归母净利润-1764万美元,同比去年增长45.17%
|
| 2025-03-07 |
股东大会：
将于2025-04-17召开股东大会
会议内容 ▼▲
- 1.To grant discretionary authority to our board of directors to (i) amend our articles of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-three (1-for-3)] to a maximum of a one-for-twenty-two (1-for-22)], with the exact ratio to be determined by our board of directors in its sole discretion; (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Stock Split Proposal”)
2.To authorize, for purposes of complying with Nasdaq listing rule 5635(d), the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on February 19, 2025 (the “Issuance Proposal”)
3.To amend the articles of incorporation to increase the authorized shares of Class A common stock from 600,000,000 shares to 1,800,000,000 shares (the “Authorized Common Stock Increase Proposal”)
4.To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Reverse Stock Split Proposal, the Issuance Proposal and the Authorized Common Stock Increase Proposal if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal, Authorized Common Stock Increase Proposal or the Issuance Proposal (the “Adjournment Proposal”)
5.To consider and transact such other business as may be properly brought before the Special Meeting and any adjournments thereof.
|
| 2024-12-04 |
股东大会：
将于2024-12-31召开股东大会
会议内容 ▼▲
- 1.To elect the five director nominees named in the Proxy Statement;
2.To ratify the appointment of PKF O’Connor Davies, LLP (“PKF”) as our independent registered public accounting firm for our fiscal year ending December 31, 2024;
3.To approve and ratify an amendment to the 2019 Equity Incentive Plan, including the reservation of 317,568 shares of common stock thereunder (the “2019 Equity Incentive Plan”);
4.To approve, in accordance with Nasdaq listing rule 5635(d), the amendment of the 2024 August Warrant (the “2024 August Warrant”) to purchase common stock in connection with an offering, and sale of securities of the Company that was consummated on August 13, 2024, to decrease the floor price provision in the event that the Company effects a Reverse Stock Split of its common stock in the future (the “Reverse Split Floor Price Decrease Proposal”) (the “August Warrant Proposal”);
5.To approve an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the 2019 Equity Incentive Plan Proposal and/or the Reverse Split Floor Price Decrease Proposal (the “Adjournment Proposal”).;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) of the Annual Meeting.
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-12.2美元,归母净利润-886.5万美元,同比去年增长68.16%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-13.69美元,归母净利润-510.6万美元,同比去年增长71.19%
|
| 2024-08-05 |
详情>>
拆分方案：
每11.0000合并分成1.0000股
|
| 2024-07-25 |
详情>>
业绩披露：
2024年一季报每股收益-0.85美元,归母净利润-449.1万美元,同比去年增长48.34%
|
| 2024-07-19 |
详情>>
业绩披露：
2023年年报每股收益-8.16美元,归母净利润-3217.5万美元,同比去年增长81.02%
|
| 2024-06-28 |
股东大会：
将于2024-07-29召开股东大会
会议内容 ▼▲
- 1.To approve the adoption of an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”), to be filed not later than August 5, 2024, to effect a reverse stock split of our Class A Common Stock (as defined below) at a ratio in the range of one-for-two to one-for-20 (collectively, the “Reverse Split”), with such ratio to be determined in the discretion of the Board of Directors of the Company (the “Board”) and publicly disclosed prior to the effectiveness of the Reverse Split (the “Reverse Split Proposal”).
|
| 2024-01-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-9.67美元,归母净利润-2784.2万美元,同比去年增长82.37%
|
| 2023-06-07 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2023-05-15 |
财报披露：
美东时间 2023-05-15 盘后发布财报
|
| 2023-04-27 |
股东大会：
将于2023-05-26召开股东大会
会议内容 ▼▲
- 1.To elect the five director nominees named in the Proxy Statement;
2.To ratify the appointment of Marcum LLP (“Marcum”) as our independent registered public accounting firm for our fiscal year ending December 31, 2023;
3.To approve the adoption of an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”), to be filed not later than November 20, 2023, to effect a reverse stock split of our Class A Common Stock (as defined below) at a ratio in the range of 1-for-five to 1-for-15 (collectively, the “Reverse Split”), with such ratio to be determined in the discretion of the Board and publicly disclosed prior to the effectiveness of the Reverse Split (the “Reverse Split Proposal”);
4.To approve an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Split Proposal or the Third Amendment and Restatement (as defined below) (the “Adjournment Proposal”);
5.To approve the Third Amended and Restated Greenlane Holdings, Inc. 2019 Equity Incentive Plan; and (the “Third Amendment and Restatement”);
6.To transact such other business as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) of the Annual Meeting.
|
| 2022-08-10 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2022-06-21 |
股东大会：
将于2022-08-04召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the proxy statement;
2.To ratify the appointment of marcum llp (“marcum”) as our independent registered public accounting firm for our fiscal year ending december 31, 2022;
3.To approve the adoption of an amendment to the company’s amended and restated certificate of incorporation (the “charter”), to be filed not later than february 10, 2023, to effect a reverse stock split of our common stock (as defined below) at a ratio in the range of 1-for-five to 1-for-20 (collectively, the “reverse split”), with such ratio to be determined in the discretion of the board and publicly disclosed prior to the effectiveness of the reverse split;
4.To approve the second amended and restated greenlane holdings, inc. 2019 equity incentive plan;
5.To transact such other business as may properly come before the annual meeting or any adjournment(s) or postponement(s) of the annual meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-02 |
股东大会：
将于2021-08-26召开股东大会
会议内容 ▼▲
- 1.a proposal to elect the five director nominees named in this joint proxy statement/prospectus, each for a term expiring at Greenlane’s 2022 annual meeting of stockholders; provided that Neil Closner has executed a conditional resignation letter that will become effective if the Mergers (as defined below) are completed as described elsewhere in this joint proxy statement/prospectus (the “Greenlane Director Proposal”);
2.a proposal to ratify Deloitte & Touche LLP (“Deloitte”) as Greenlane’s independent registered public accounting firm for Greenlane’s fiscal year ending December 31, 2021 (the “Greenlane Auditor Proposal”);
3.a proposal to consider and vote upon the approval and adoption of the definitive agreement and plan of merger (the “Merger Agreement”), dated as of March 31, 2021, by and among Greenlane, Merger Sub Gotham 1, LLC, a wholly-owned subsidiary of Greenlane (“Merger Sub 1”), Merger Sub Gotham 2, LLC, a wholly owned subsidiary of Greenlane (“Merger Sub 2”) and KushCo Holdings, Inc. (“KushCo”). Pursuant to the Merger Agreement, Greenlane and KushCo will combine through a merger of Merger Sub 1 with and into KushCo with KushCo as the surviving corporation and a wholly owned subsidiary of Greenlane (“Initial Surviving Corporation”) (such merger, “Merger 1”) and a merger of the Initial Surviving Corporation with and into Merger Sub 2 with Merger Sub 2 as the surviving limited liability company and a wholly owned subsidiary of Greenlane (“Merger 2,” and, together with Merger 1, the “Mergers”) (the “Greenlane Merger Proposal”);
4.a proposal to consider and vote upon the approval and adoption of the Amended and Restated Certificate of Incorporation of Greenlane (the “Greenlane Charter Amendment Proposal”);
5.a proposal to consider and vote upon the approval of the issuance of Greenlane Class A common stock in connection with the closing of Merger 1 (the “Greenlane Stock Issuance Proposal”);
6.a proposal to consider and vote upon the Amended and Restated Greenlane Holdings, Inc. 2019 Equity Incentive Plan (the “Greenlane Plan Proposal”);
7.a proposal to approve one or more adjournments of the Greenlane annual meeting to another date, time and/or place, if necessary or appropriate, to solicit additional proxies in favor of the Greenlane Merger Proposal, the Greenlane Charter Amendment Proposal or the Greenlane Stock Issuance Proposal (the “Greenlane Adjournment Proposal”).
|
| 2020-04-24 |
股东大会：
将于2020-06-04召开股东大会
会议内容 ▼▲
- 1.to elect the five director nominees named in the Proxy Statement;
2.registered public accounting firm for our fiscal year ending December 31, 2020;
3.to transact such other business as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) of the Annual Meeting.
|